SEARCH

SEARCH BY CITATION

References

  • 1
    Mattsson C, Young WF. Primary aldosteronism: diagnostic and treatment strategies. Nat Clin Pract Nephrol. 2006;2:198208.
  • 2
    Mantero F, Mattarello MJ, Albiger NME. Detecting and treating primary aldosteronism. Exp Clin Endocrinol Diabetes. 2007;115:171174.
  • 3
    Milliez P, Girerd X, Plouin PF, et al. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol. 2005;45:12431248.
  • 4
    Rossi GP, Bernini G, Caliumi C, et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol. 2006;48:22932300.
  • 5
    Giacchetti G, Ronconi V, Lucarelli G, et al. Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: need for a standardized protocol. J Hypertens. 2006;24:737745.
  • 6
    Goh BK, Tan YH, Chang KT, et al. Primary hyperaldosteronism secondary to unilateral adrenal hyperplasia: an unusual cause of surgically correctable hypertension. A review of 30 cases. World J Surg. 2007;31:7279.
  • 7
    Doppman JL, Gill JR, Miller DL, et al. Distinction between hyperaldosteronism due to bilateral hyperplasia and unilateral aldosteronoma: reliability of CT. Radiology. 1992;184:677682.
  • 8
    Phillips JL, Walther MM, Pezzullo JC, et al. Predictive value of preoperative tests in discriminating bilateral adrenal hyperplasia from an aldosterone-producing adrenal adenoma. J Clin Endocrinol Metab. 2000;85:45264533.
  • 9
    Rossi GP, Sacchetto A, Chiesura-Corona M, et al. Identification of the etiology of primary alsdosteronism with adrenal vein sampling in patients with equivocal computed tomography and magnetic resonance findings: results in 104 consecutive cases. J Clin Endocrinol Metab. 2001;86:10831090.
  • 10
    Young WF, Stanson AW, Thompson GB, et al. Role for adrenal venous sampling in primary aldosteronism. Surgery. 2004;136:12271235.
  • 11
    Tan YY, Ogilvie JB, Triponez F, et al. Selective use of adrenal venous sampling in the lateralization of aldosterone-producing adenomas. World J Surg. 2006;30:879885.
  • 12
    Harvey A, Kline G, Pasieka JL. Adrenal venous sampling in primary hyperaldosteronism: comparison of radiographic with biochemical success and the clinical decision-making with “less than ideal” testing. Surgery. 2006;140:847855.
  • 13
    Carr CE, Cope C, Cohen DL, et al. Comparison of sequential versus simultaneous methods of adrenal venous sampling. J Vasc Interv Radiol. 2004;15:12451250.
  • 14
    Zarnegar R, Bloom AI, Lee J, et al. Is adrenal venous sampling necessary in all patients with hyperaldosteronism before adrenalectomy? J Vasc Interv Radiol. 2008;19:6671.
  • 15
    Gallay BJ, Ahmad S, Xu L, et al. Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio. Am J Kidney Dis. 2001;37:699705.
  • 16
    Nishizaka MK, Pratt-Ubunama M, Zaman MA, et al. Validity of plasma aldosterone-to-renin activity in African American and white subjects with resistant hypertension. Am J Hypertens. 2005;18:805812.
  • 17
    Schwartz GL, Turner ST. Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity. Clin Chem. 2005;51:386394.
  • 18
    Funder JW, Carey RM, Fardella C, et al. Case detection, diagnosis and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008;93:32663281.
  • 19
    Rossi GP, Ganzalori C, Miotto D, et al. Dynamic testing with adrenocorticotropic hormone does not improve lateralization of aldosterone oversecretion in primary aldosteronism patients. J Hypertens. 2006;24:371379.
  • 20
    Rossi GP, Pitter G, Bernante P, et al. Adrenal vein sampling for primary aldosteronism: assessment of selectivity and lateralization of aldosterone excess baseline and after adrenocorticotropic hormone (ACTH) stimulation. J Hypertens. 2008;26:989997.
  • 21
    Sawka AM, Young WF, Thompson GB, et al. Primary aldosteronism: factors associated with normalization of blood pressure after surgery. Ann Intern Med. 2001;135:258261.
  • 22
    Horita Y, Inenaga T, Nakahama H, et al. Cause of residual hypertension after adrenalectomy in patients with primary aldosteronism. Am J Kidney Dis. 2001;37:884889.
  • 23
    Sywak M, Pasieka JL. Long-term follow-up and cost benefit of adrenalectomy in patients with primary hyperaldosteronism. Br J Surg. 2002;89:15871593.
  • 24
    Fukudome Y, Fujii K, Arima H, et al. Discriminating factors for recurrent hypertension in patients with primary aldosteronism after adrenalectomy. Hypertens Res. 2002;25:1118.
  • 25
    Meyer A, Brabant G, Behrend M. Long-term follow-up after adrenalectomy for primary aldosteronism. World J Surg. 2005;29:155159.
  • 26
    Tsujihata M, Nonomura N, Tsujimura A, et al. Laparoscopic adrenalectomy for primary hyperaldosteronism: clinical experience with 60 cases. J Endocrinol. 2006;20:262265.
  • 27
    Rossi GP, Belfiore A, Bernini G, et al. Comparison of the captoril and saline infusion test for excluding aldosterone-producing adenoma. Hypertension. 2007;50:424431.
  • 28
    Calhoun DA, Jones D, Textor S, et al. Resistant hypertension: diagnosis, evaluation and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure research. Hypertension. 2008;51:14031419.